Background and introduction
===========================

Excessive licorice intake is a well-known cause of hypertension. The licorice compound glycyrrhizin inhibits the enzyme 11-beta-hydroxysteroid dehydrogenase type two (11β-HSD2), which is found in the kidney tubules. The enzyme inactivates cortisol to cortisone. Cortisol stimulates the mineralocorticoid receptor (MCR) and by inactivation of cortisol this stimulation is reduced. When licorice inhibits 11β-HSD2, the cortisol level rises stimulating the MCR excessively. This, in turn, leads to resorption of sodium, secretion of potassium, and increase in blood pressure. The condition mimics high levels of mineralocorticoids known as pseudohyperaldosteronism (PsHA) or syndrome of apparent mineralocorticoid excess (SAME) ([@bib1]). Severe hypokalemia may trigger electrocardiogram (ECG) changes such as arrhythmias, flattened T-waves, long QT interval, and ultimately cardiac arrest/sudden death ([@bib2]).

This case report emphasizes that licorice may induce pseudohyperaldosteronism, hypertension, hypokalemia, and ECG changes. The diagnosis is easily missed as the intake of licorice should be asked for specifically when covering the patient's history.

Case presentation
=================

A 43-year-old female with a medical history of hypertension and myxedema was admitted to the Regional Hospital of Horsens, Denmark, with flu-like symptoms, chest pain, and a stinging sensation in both upper extremities. The symptoms were alternating present 14 days prior to admission. Everyday medication included three antihypertensive medications (beta block, angiotensin-converting enzyme (ACE) inhibitor in combination with a thiazide-like diuretic): metoprolol 50 mg × 1 and perindopril 1.25 mg × 1 + indapamid 5 mg. Previously, she was treated with four different types of antihypertensive medications. The physical examination and vital signs revealed no abnormalities except from a high blood pressure (160/81 mmHg) and a temperature of 39°C. An influenza test was positive. There was no vomiting. Blood tests revealed severe hypokalemia of 1.9 mmol/L, elevated C reactive protein, and normal white blood cell count, the latter being compatible with viral infection ([Table 1](#tbl1){ref-type="table"}). The ECG showed sinus rhythm, no signs of ischemia, but a significant long QT interval, QTc = 476 ms (cutoff points for women ≤450 ms (normal), 451 to 470 ms (borderline), and \>470 ms (prolonged) ([@bib3])). The ECG also showed flattened T-waves ([Fig. 1](#fig1){ref-type="fig"}). Telemetry revealed no arrhythmias. The patient had consumed licorice sweets and been drinking licorice tea regularly for many years. Three weeks prior to admission this intake was increased to around 480 g of licorice sweets per week.Figure 1ECG at admission with flattened T-waves and long QT. ECG recording: 25 mm/s, 10 mm/mV. Table 1Blood test.AnalysisUnitReference rangeDay 1Day 13K^+^mmol/L3.5--4.6**1.9**4.5Na^+^mmol/L137--145143141Magnesiummmol/L0.70--1.100.840.85Creatinineμmol/L45--908081CRPmg/L\<8.0**52.9**--Leucocytes\*10^9^/L3.5--10.05.58--Renin\*10^−3^ IU----11.9Aldosteronepmol----140Aldosterone/reninnmol/IU\<31.011.8[^1][^2]

The combination drug indapamid + perindopril was paused as hypokalemia was initially suspected to be a side effect to indapamid (a thiazide-like drug). She was treated with 292 mmol potassium orally and intravenously for the first 24 h of admission. Despite the great amount of potassium, p-potassium only increased to 2.6 mmol/L. The following 4 days, she received another 362 mmol potassium-normalizing p-potassium to 3.4 mmol/L (1st 24 h: 7500 mg potassium chloride tablets (100 mmol), 90 mmol potassium chloride oral suspension, 1 liter Potassium-Sodium-Glucose infusion (51 mmol) and 1 liter Potassium-Sodium-Chloride infusion (51 mmol) → P-potassium 2.6 mmol/L. 2nd--4th day: 1 liter Potassium-Sodium-Glucose infusion (51 mmol), 1 liter Potassium-Chloride-Glucose infusion (51 mmol), in total 19,500 mg potassium chloride tablets (260 mmol) → P-potassium 3.4 mmol/l. 5th day and on: potassium chloride 2250 mg × 2 tablets (60 mmol)) ([Fig. 2](#fig2){ref-type="fig"}). The paresthesia eased within the first 24 h. She was discharged from the hospital with p-potassium of 3.4 mmol/L and continued oral treatment with potassium chloride 2250 mg × 2 until follow-up in the outpatient clinic of endocrinology. Here the medication was adjusted.Figure 2P-Potassium at admission day (day 1) to day 13 after starting substitution with potassium.

The peak blood pressure during admission was 177/98 mmHg. The high blood pressure and hypokalemia together with the history of increased intake of licorice led to the diagnosis of PsHA alternatively primary hyperaldosteronism (PHA). The antihypertensive drugs were changed in order to examine for the tentative diagnosis (see Discussion).

Two weeks after discharge p-renin, p-aldosterone and aldosterone/renin ratio were all normal and PHA was ruled out ([Table 1](#tbl1){ref-type="table"}). The blood pressure lowered to 128/86 mmHg, and the antihypertensive regimen was reduced to monotherapy with losartan 50 mg × 1. Further, she was advised to stop using oral contraceptives. A new ECG showed normalization of the QT interval (QTc = 394 ms) ([Fig. 3](#fig3){ref-type="fig"}). P-potassium was monitored for 5 weeks after discharge, and potassium chloride was stepwise reduced to 750 mg × 1. She then transferred back to her general practitioner for further adjustment of the antihypertensive medication and potassium chloride.Figure 3ECG 3 weeks after discharge with normal T-waves and QT interval. ECG recording: 25 mm/s, 10 mm/mV.

Discussion
==========

Here we present a case of licorice-induced PsHA/SAME. The female patient had increased her licorice intake 3 weeks prior to admission presenting with symptoms comprising of chest pain, paresthesia, and deranged wellbeing. She had low p-potassium, flattened T-waves, and long QT interval in the ECG. Potassium levels were corrected and the licorice intake was stopped. The ECG normalized, blood pressure dropped, and antihypertensive treatment was heavily reduced.

The patient had ingested about 70 g of licorice daily and had also been drinking licorice tea (unknown amount). Even as little as 50 g of licorice (75 mg glycyrrhetinic acid) daily may increase the risk of hypertension ([@bib4]).

The patient presented with long QT interval in the initial ECG. To our knowledge, only a few other cases of excessive licorice intake and long QT interval have been reported ([@bib5], [@bib6]). It is of great importance to recognize long QT interval in the ECG as it may lead to torsades the point, ventricular fibrillation, and even cardiac arrest/sudden death ([@bib3], [@bib6]). According to guidelines, treatment of hypokalemia depends on the presence of ECG changes and the severity of the hypokalemia. With present ECG changes, intravenous substitution is advised as opposed to no ECG changes where oral substitution is sufficient ([@bib7]). In this case the long QT interval resolved after correcting p-potassium ([Figs 1](#fig1){ref-type="fig"} and [@bib3]).

This case also demonstrates that great amounts of potassium are needed to correct levels of p-potassium, and it illustrates the massive depletion of intracellular potassium due to licorice-induced PsHA. From guidelines the need to correct severe hypokalemia is usually 40--100 mmol potassium per day ([@bib8]). Our patient was hospitalized for 4 days until the potassium level was sufficiently corrected. During hospitalization she received an average of 163.5 mmol per day. P-potassium drops approximately 0.3 mmol for every 100 mmol whole body potassium depletion ([@bib7]). This estimates a deficit of some 500 mmol in our patient on top of 40 mmol daily to ensure normal potassium homeostasis ([@bib9]) leading to a total need of 660 mmol during the first 4 days of hospitalization. The estimate corresponds well to the 654 mmol she received during hospitalization. Despite correction of p-potassium, an increased daily intake of potassium was still needed after 4 days of treatment, as it takes time for PsHA to resolve.

The patient was previously examined at the department of nephrology (2010) and at the department of cardiology (2014) because of hypertension and young age trying to cover causes of secondary hypertension. Hypertension and hypokalemia are symptoms of PHA and PsHA. P-renin and p-aldosterone are both low when suffering from PsHA/SAME ([@bib1]) as opposed to PHA where p-renin is low and p-aldosterone is high ([@bib10]). Many antihypertensive drugs interfere with the renin-angiotensin-aldosterone system. Therefore, most antihypertensive drugs must be paused for about four weeks for example thiazides and licorice must be paused. Only a few antihypertensive drugs are suitable without pause including α-receptor antagonists and non-dihydropyridin calcium antagonists. Furthermore, p-potassium must be within normal range when measuring renin, aldosterone, and aldosterone/renin ratio ([@bib10]). All were normal at follow-up examination whereby PHA was ruled out and PsHA was found to be the most likely diagnosis. The patient was treated with indapamid (a thiazide-like drug) prescribed in a moderate dose prior to admission. It is a common drug used to treat hypertension. The hypokalemia in this case was severe and we therefore consider the PsHA diagnosis more likely than a side effect to indapamid.

Finally, the case highlights the importance of a sufficient and detailed patient history. Our patient was previously prescribed four different antihypertensive drugs and was examined in two different specialized hospital departments. If licorice intake came to attention by asking, one could speculate, that the antihypertensive medication and examination in specialized units could have been avoided.
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[^1]: Abnormal values are presented in bold face.

[^2]: CRP, C-reactive-protein; Na^+^, sodium; K^+^, potassium.
